| |
| |
|
| Insider
Information: |
Frost Gregory Ian |
| Relationship: |
SVP--Health Sector |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,941,380 |
|
|
Indirect Shares
|
190,072 |
|
|
| Direct
Value |
$188,175,139 |
|
|
|
Indirect Value
|
$9,798,212 |
|
|
| Total
Shares |
4,131,452 |
|
|
| Total
Value |
$197,973,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
CEO, President, Director |
2013-12-11 |
3,641,380 |
2004-03-11 |
190,072 |
Premium* |
|
|
Precigen Inc |
PGEN |
SVP--Health Sector |
2015-05-28 |
300,000 |
2014-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
SVP--Health Sector |
• – – |
2015-05-28 |
4 |
OE |
$22.77 |
$4,554,000 |
D/D |
200,000 |
300,000 |
0 |
- |
|
| PGEN |
Precigen Inc |
SVP--Health Sector |
• – – |
2014-03-04 |
4 |
B |
$26.04 |
$1,510,511 |
D/D |
58,000 |
100,000 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2008-03-20 |
4 |
S |
$6.06 |
$1,393,800 |
D/D |
(230,000) |
3,530,866 |
0 |
- |
|
| PGEN |
Precigen Inc |
SVP--Health Sector |
• – – |
2014-02-28 |
4 |
B |
$25.93 |
$998,290 |
D/D |
38,500 |
38,500 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2008-03-19 |
4 |
OE |
$0.43 |
$275,158 |
D/D |
639,902 |
3,789,508 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
• • – |
2007-07-06 |
4 |
AS |
$9.65 |
$245,553 |
D/D |
(25,000) |
2,929,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-06-06 |
4/A |
AS |
$10.50 |
$211,455 |
D/D |
(20,000) |
2,887,365 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-06-06 |
4 |
AS |
$10.50 |
$211,455 |
D/D |
(20,000) |
2,077,365 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-06-07 |
4 |
AS |
$10.30 |
$209,487 |
D/D |
(20,000) |
2,077,365 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-06-07 |
4/A |
AS |
$10.30 |
$209,487 |
D/D |
(20,000) |
2,887,365 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2008-03-19 |
4 |
D |
$6.06 |
$173,571 |
D/D |
(28,642) |
3,760,866 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Scientific Ofcr |
• • – |
2007-07-05 |
4 |
AS |
$9.59 |
$144,267 |
D/D |
(15,000) |
2,929,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-09-26 |
4 |
AS |
$8.93 |
$135,864 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-10-25 |
4 |
AS |
$8.91 |
$135,377 |
D/D |
(15,000) |
3,069,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-10-24 |
4 |
AS |
$8.91 |
$134,761 |
D/D |
(15,000) |
3,069,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-09-27 |
4 |
AS |
$8.76 |
$133,563 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-08-30 |
4 |
AS |
$8.34 |
$126,752 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-08-29 |
4 |
AS |
$8.16 |
$124,185 |
D/D |
(15,000) |
3,019,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-08-01 |
4 |
AS |
$7.92 |
$120,650 |
D/D |
(15,000) |
2,969,606 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2006-11-30 |
5 |
GD |
$2.89 |
$115,597 |
D/D |
39,999 |
3,023,780 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
CEO, President |
• • – |
2013-12-11 |
4 |
OE |
$2.02 |
$101,993 |
D/D |
50,000 |
3,641,380 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-08-02 |
4/A |
AS |
$7.99 |
$100,951 |
D/D |
(12,601) |
2,969,606 |
0 |
- |
|
| PGEN |
Precigen Inc |
SVP--Health Sector |
• – – |
2014-03-03 |
4 |
B |
$24.59 |
$86,052 |
D/D |
3,500 |
42,000 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-11-20 |
4 |
AS |
$7.57 |
$76,803 |
D/D |
(9,800) |
3,111,506 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
• • – |
2007-11-21 |
4 |
AS |
$7.51 |
$76,246 |
D/D |
(10,000) |
3,109,606 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
